baber/WOPTO huggingface dataset:
Patent CY-1115382-T1 (CY)
Title: Συνθεσεις και μεθοδοι για αναστολη toy pdgfrb και toy vegf-a
Inventor: SIVAKUMAR PALLAVUR V
IPC: A61K39/395
Filed: 2014-05-23
Abstract: Αποκαλύπτονται ανταγωνιστές του PDGF υποδοχέα β (PDGFRβ) και του VEGF-A, μεταξύ αυτών εξουδετερωτικά αντισώματα αντι-PDGFRβ και εξουδετερωτικά αντισώματα αντι-VEGF-A, καθώς και σχετικές συνθέσεις και μέθοδοι. Στα αντι-PDGFRβ και αντι-VEGF-A αντισώματα που αποκαλύπτονται εδώ περιλαμβάνονται διπλοειδικά αντισώματα ικανά να δεσμευθούν και να εξουδετερώσουν τόσο τον PDGFRβ όσο και τον VEGF-A. Επίσης αποκαλύπτονται μέθοδοι αγωγής νεοαγγειακής διαταραχής, όπως καρκίνου ή νεοαγγειακής οφθαλμικής διαταραχής, χρησιμοποιώντας PDGFRβ και/ή VEGF-A ανταγωνιστή.
Patent CY-1116231-T1 (CY)
Title: ΑΛΑΤΑ ΥΠΟΚΑΤΕΣΤΗΜΕΝΗΣ 2,3-ΔIYΔPOΪMIΔAZO[l,2-C] ΚΙΝΑΖΟΛΙΝΗΣ
Inventor: PETERS JAN GEORG
IPC: A61K31/519
Filed: 2015-02-19
Abstract: Η παρούσα εφεύρεση σχετίζεται με διυδροχλωρικό άλας 2-αμινο-Ν-[7-μεθοξυ-8-(3-μορφολιν-4-υλοπροποξυ)-2,3-διυδροϊμιδαζο-[1,2-c]-κιναζολιν-5-υλο]πυριμιδινο-5-καρβοξαμιδίου του τύπου (II) ή ταυτομερές, επιδιαλυτωμένο σύμπλεγμα ή ένυδρο σύμπλεγμα αυτού• με μεθόδους παρασκευής του εν λόγω διυδροχλωρικού άλατος• με το εν λόγω διυδροχλωρικό άλας για τη θεραπευτική αγωγή και/ή προφύλαξη πάθησης• με τη χρήση του εν λόγω διυδροχλωρικού άλατος για την παρασκευή φαρμάκου για τη θεραπευτική αγωγή και/ή προφύλαξη πάθησης, ιδίως υπερπολλαπλασιαστικής διαταραχής και/ή διαταραχής αγγειογένεσης, πιο συγκεκριμένα για τη θεραπευτική αγωγή ή προφύλαξη καρκίνου, ιδίως καρκίνου πνεύμονα, ιδίως μη-μικροκυτταρικού καρκίνου πνεύμονα, ορθοκολικού καρκίνου, μελανώματος, παγκρεατικού καρκίνου, καρκινώματος ηπατοκυττάρων, παγκρεατικού καρκίνου, καρκινώματος ηπατοκυττάρων ή καρκίνου μαστού• με φαρμακευτική σύνθεση που περιλαμβάνει το εν λόγω διυδροχλωρικό άλας• και με φαρμακευτικό συνδυασμό που περιλαμβάνει το εν λόγω διυδροχλωρικό άλας σε συνδυασμό με έναν ή περισσότερους φαρμακευτικούς παράγοντες.
Patent CY-1116352-T1 (CY)
Title: Αντιυπερτασικοι παραγοντες διπλης δρασης
Inventor: ALLEGRETTI PAUL
IPC: C07D401/10
Filed: 2015-03-17
Abstract: Η εφεύρεση αφορά ενώσεις που διαθέτουν το χημικό τύπο (I) όπου τα Ar, r, Υ, Ζ, Q, W, Χ και R5-7 ορίζονται στην περιγραφή, καθώς και φαρμακευτικά αποδεκτά άλατα αυτών. Οι εν λόγω ενώσεις διαθέτουν δραστηριότητα ανταγωνιστή υποδοχέα ΑΤ1 και ανασταλτική δραστηριότητα νεπριλυσίνης. Η εφεύρεση αφορά επίσης φαρμακευτικές συνθέσεις οι οποίες περιλαμβάνουν αυτού του είδους τις ενώσεις' μεθόδους χρήσης αυτών των ενώσεων' και διαδικασίες και ενδιάμεσα για την παρασκευή αυτών των ενώσεων.
Patent CY-1117242-T1 (CY)
Title: Νεες ενωσεις υποκατεστημενης κινολινης ως αναστολεις αναγωγασης s-νιτροζογλουταθειονης
Inventor: SUN XICHENG
IPC: C07D215/20
Filed: 2015-11-26
Abstract: Η παρούσα εφεύρεση κατευθύνεται σε νέες ενώσεις κινολίνης χρήσιμες ως αναστολείς αναγωγάσης S-νιτροζογλουταθειόνης (GSNOR), φαρμακευτικές συνθέσεις που περιλαμβάνουν τέτοιες ενώσεις και μεθόδους κατασκευής και χρήσης αυτών.
Patent CY-1121026-T1 (CY)
Title: Μεθοδος για τον σχηματισμο διακλαδωσεων απομιμησης
Inventor: DEJANS OLIVIER
IPC: B29C48/09
Filed: 2018-11-01
Abstract: Η παρούσα εφεύρεση σχετίζεται με μια μέθοδο για τον σχηματισμό διακλαδώσεων απομίμησης (1), όπου μια μάζα πολυμερούς, η οποία περιλαμβάνει ένα διαστελλόμενο πλαστικό τήκεται υπό πίεση για τον σχηματισμό ενός πρώτου μίγματος, στη συνέχεια οδηγείται μέσω μιας κεφαλής εξωθητή (2) και ελκύεται από αυτήν την κεφαλή εξώθησης (2) με τη μορφή ενός επιμήκους πλαστικού κλώνου (3), όπου η μέθοδος περαιτέρω περιλαμβάνει τα ακόλουθα στάδια:
Patent CY-1121359-T1 (CY)
Title: Ενωσεις ετεροαρυλιου για αναστολη κινασης
Inventor: HUANG WEI-SHENG
IPC: C07D471/04
Filed: 2019-03-12
Abstract: Στο κείμενο περιγράφονται ενώσεις και φαρμακευτικές συνθέσεις οι οποίες διαμορφώνουν ενεργότητα κινάσης, όπως ενεργότητα μεταλλαγμένης EGFR κινάσης και μεταλλαγμένης HER2 κινάσης, και ενώσεις, φαρμακευτικές συνθέσεις, και μέθοδοι αγωγής παθήσεων και καταστάσεων συναφών με την εν λόγω ενεργότητα κινάσης, όπως την ενεργότητα μεταλλαγμένου EGFR και μεταλλαγμένου HER2.
Patent CY-1123385-T1 (CY)
Title: Υψηλης συγγενειας pd-1 παραγοντες και μεθοδοι χρησης
Inventor: RING AARON MICHAEL
IPC: C07K14/705
Filed: 2020-08-05
Abstract: Παρέχονται υψηλής συγγένειας PD-1 μιμητικά πολυπεπτίδια, τα οποία (i) περιλαμβάνουν τουλάχιστον μία αλλαγή αμινοξέος σχετικά με μία άγριου τύπου PD-1 πρωτεΐνη• και (ii) έχουν μία αυξημένη συγγένεια για PD-L1 σχετικά με την πρωτεΐνη άγριου τύπου. Οι συνθέσεις και οι μέθοδοι παρέχονται για τροποποίηση της δραστικότητας ανοσοκυττάρων σε ένα θηλαστικό δια χορήγησης μιας θεραπευτικής δόσης μιας φαρμακευτικής σύνθεσης που περιλαμβάνει ένα υψηλής συγγένειας PD-1 μιμητικό πολυπεπτίδιο, το οποίο αποκλείει τη φυσιολογική αλληλεπίδραση δέσμευσης μεταξύ PD-1 και του προσδέτη αυτού PD-L1 και/ή PD-L2.
Patent CY-1123967-T1 (CY)
Title: Στερεη συνθεση για τη χορηγηση απο το στομα χρωστικων υλων και διαγνωστικη χρηση αυτης
Inventor: MORO LUIGI
IPC: A61K49/00
Filed: 2021-03-18
Abstract: Στο παρόν περιγράφονται στερεές συνθέσεις για τη χορήγηση από το στόμα χρωστικών υλών και η διαγνωστική χρήση αυτών. Κατά προτίμηση, αυτή η διαγνωστική χρήση στοχεύει στη διαγνωστική αξιολόγηση του γαστρεντερικού σωλήνα.
Patent CY-1124752-T1 (CY)
Title: Σταλακτης και μεθοδος διανοιξης οπων εξοδου του νερου
Inventor: DERMITZAKIS EMMANUIL
IPC: A01G25/02
Filed: 2021-11-10
Abstract: Ο σταλάκτης άρδευσης (1) της παρούσας εφεύρεσης εισάγεται και επικολλάται στο εσωτερικό ενός σταλακτηφόρου σωλήνα (2) κατά την φάση της παραγωγής του. Φέρει αριθμό από προεξοχές (8) που ανυψώνονται διατεταγμένε ς σε σειρά από στερεό και πλήρες τμήμα (6) της εξωτερικής κυρτής επιφάνειας (7) του σταλάκτη (1) . Ο σωλήνας (2) διογκώνεται τοπικά, επικαλύπτει και επικολλάται τόσο πάνω στις προεξοχές (8) όσο και στην βάση τους (6) προκειμένου να δημιουργηθεί μεταξύ προεξοχών (8) και σωλήνα, ένα ενιαίο συγκολλημένο σύνολο. Οι έξοδοι του νερού (10) δημιουργούνται κατά κανόνα μεταξύ των πρισματικών προεξοχών (8) με την αποκοπή των άκρων των προεξοχών (8) κατά την διέλευση του σταλακτηφόρου σωλήνα μέσα από μια συνεχώς περιστρεφόμενη κοίλη φρέζα (35) τοποθετημένη στο τέρμα της γραμμής παραγωγής. Η κοπή γίνεται αφού προηγουμένως ο σωλήνας περάσει μέσα από σύστημα διαδοχικών ζευγών κοίλων και κυρτών ράουλων που τον συμπιέζουν, τον τεντώνουν και του προσδίδουν δυσκαμψία διατηρώντας τον σε πεπλατυσμένη κυρτή και κεκαμμένη μορφή.
Patent CY-1124733-T1 (CY)
Title: Antimykhtiaσιko φαρμακευτικο σκευασμα
Inventor: LAW DEREK
IPC: A61K31/506
Filed: 2021-11-19
Abstract: Παρέχεται μια φαρμακευτική σύνθεση κατάλληλη για χορήγηση από του στόματος που περιλαμβάνει σωματίδια 2-(1,5-διμεθυλο-3-φαινυλο-1H-πυρρολο-2-υλο)-Ν-(4-(4-(5-φθοροπυριμιδιν-2-υλο)πιπεραζιν-1-υλο)φαινυλο)-2-οξοακεταμιδίου. Παρέχεται επίσης μια φαρμακευτική σύνθεση κατάλληλη για παρεντερική χορήγηση όπου η σύνθεση περιλαμβάνει 2-(1,5-διμεθυλο-3-φαινυλο-1Η-πυρρολο-2-υλο)-Ν-(4-(4-(5-φθοροπυριμιδιν-2-υλο)πιπεραζιν-1-υλο)φαινυλο)-2-οξοακεταμίδιο. Οι συνθέσεις είναι χρήσιμες στη θεραπευτική αντιμετώπιση μυκητιασικής λοίμωξης σε ένα υποκείμενο που το έχει ανάγκη.
Patent HR-P20100339-T1 (HR)
Title: Indole derivatives as ppar activators
Inventor: BINET JEAN
IPC: A61K31/405
Filed: 2010-06-15
Abstract: Indole derivatives (I), are new. Indole derivatives of formula (I) and their salts are new. R a, R bH, halo, 1-6C alkyl, CF 3, CN, COR 2, OR 2 or phenyl (optionally substituted by 1-4C alkyl or CF 3); R 21-4C alkyl, CF 3 or phenyl (optionally substituted by 1-4C alkyl or CF 3); R 2H or 1-4C alkyl; R : H or 1-3C alkyl; n : 1-3; X : a bond or O, and Ar 1phenyl, naphthyl, quinolinyl, isoquinolinyl, pyridinyl, pyrazolyl, imidazolyl, isoxazolyl, thiazolyl, benzothiazolyl, 2,1,3-benzothiadiazolyl, 3,4-dihydro-1,4-benzoxazinyl, 5,6,7,8-tetrahydronaphthlaneyl, 1,2,3,4-tetrahydroquinolinyl, 1,2,3,4-tetrahydroisoquinolinyl, 1,2,3,4-tetrahydro-2-oxoquinolinyl, 3,4-dihydro-2H-benzopyranyl, indolyl, 2,3-dihydroindolyl, 2,3-dihydrobenzofuranyl, 1,3-benzodioxolyl, 1,4-benzodioxanyl or benzoxazolyl (all optionally substituted by halo, 1-6C alkyl, CF 3, CN, CO-R 2, OR 2, NH-COR 2, morpholinyl, amino or 4-morpholinosulfonyl). Independent claims are included for the preparation of (I). [Image] ACTIVITY : Antilipemic; Antidiabetic; Cardiovascular-Gen.; Antiinflammatory; Neuroprotective; Nootropic; Antiparkinsonian; Anorectic; Antiarteriosclerotic; Cardiant; Hypotensive; Antiarthritic; Antirheumatic. MECHANISM OF ACTION : Peroxisome proliferator activated receptor (PPAR) activator. In a test used to determine activation of PPAR-alpha and/or PPAR-gamma , results showed that (I) exhibited an EC 50 value of 50 nM.
Patent HR-P20120516-T1 (HR)
Title: Thermal insulation system for buildings and for liquid storage and transportation systems
Inventor: BOYD COORAY
IPC: C09D7/65
Filed: 2012-06-20
Abstract: Insulating compositions in the form of aqueous dispersions which comprise hollow borosilicate glass spheres or ceramic microspheres, wax encapsulated thermoset particles and spherical thermoplastic microspheres and an emulsion polymer or redispersible powder binder. The compositions may applied as a primer or top coat in interior and/or exterior of new and existing buildings or for the insulation of pipes, cylinders and tanks containing and transporting hot or cold liquids or low boiling point liquids.
Patent HR-P20120609-T1 (HR)
Inventor: WOO SUK KO
IPC: H04N13/00
Filed: 2012-07-23
Abstract: Predajnik za oda®iljanje radiodifuzijskih podataka prijemniku naznačen time da sadr·i: FEC (Forward Error Correction = korekcija gre®ki oda®iljanja) enkoder (702-L1), konfiguriran za FEC kodiranje sloja 1 (Layer 1 ili L1) oda®iljanih podataka; pohranu bitova (na disku ili u memoriji računala) (703-L1) koja je konfigurirana za među-pohranu FEC kodiranog sloja 1 oda®iljanih podataka; QAM sustav izrade mapa (704-L1), konfiguriran za izdvajanje (demultipleksiju) među-pohranjenih bitova oda®iljanih podataka sloja 1 u stanične riječi i za izradu mapa staničnih riječi u vrijednosti skupa koje odgovaraju sloju 1 oda®iljanih podataka; uređaj za vremensku među-pohranu (1908-L1), konfiguriran za vremensku među-pohranu vrijednosti skupa iz mape koje odgovaraju sloju 1 oda®iljanih podataka, a temelje se na memoriji prema sloju 1 TI (vremenska među-pohrana), ®to je oblik informacije koja pokazuje dubinu vremenske među-pohrane, gdje je broj redaka memorije jednak dubini vremenske među-pohrane, a broj stupaca memorije je jednak kvocijentu iz podjele broja vrijednosti skupa koje su potrebne za oda®iljanje L1 podataka s dubinom vremenske među-pohrane, te gdje je dubina vremenske među-pohrane jednaka ili veća od minimalnog broja OFDM simbola koji su potrebni za prijenos L1 oda®iljanih podataka; sustav umetanja (1905-L1), konfiguriran za umetanje zaglavlja sloja 1 u vremenski pohranjene vrijednosti skupa koje odgovaraju sloju 1 oda®iljanih podataka, gdje zaglavlje sloja 1 uključuje TI oblik informacije; sredstva ponavljanja (1915-L1), konfigurirana za ponavljanje vrijednosti skupa koje odgovaraju sloju 1 oda®iljanih podataka i zaglavlju sloja 1. frekvencijsku među-pohranu (709-L1), konfiguriranu za frekvencijsku među-pohranu ponovljenih vrijednosti skupa koje odgovaraju sloju 1 oda®iljanih podataka i zaglavlju sloja 1, te sredstva (711) za stvaranje ustrojstva signala koja obuhvaćaju uvodne simbole temeljene na frekvencijski među-pohranjenim vrijednostima skupa, gdje su uvodni simboli podijeljeni na blokove sloja 1, a svaki blok sloja 1 ima 3408 prenositelja. Patent sadr·i jo® 17 patentnih zahtjeva.
Patent SI-1322286-T1 (SI)
Title: Polymeric delivery formulations of leuprolide with improved efficacy
Inventor: DUNN RICHARD L
IPC: A61K9/42
Filed: 2001-09-21
Abstract: The present invention is directed to a flowable composition that is suitable for use as a controlled release implant. The flowable composition includes a biodegradable thermoplastic polyester that is at least substantially insoluble in aqueous medium or body fluid. The flowable composition also includes a biocompatible polar aprotic solvent. The biocompatible polar aprotic solvent is miscible to dispersible in aqueous medium or body fluid. The flowable composition also includes leuprolide acetate. The present invention is also directed to a method for forming the flowable composition. The present invention is also directed to a biodegradable implant formed in situ, in a patient. The biodegradable implant is formed by injecting a flowable composition within the body of the patient and allowing the biocompatible polar aprotic solvent to dissipate to produce a solid biodegradable implant. The present invention is also directed to a method of forming a biodegradable implant in situ, in a living patient. The method includes injecting a flowable composition within the body of a patient and allowing the biocompatible polar aprotic solvent to dissipate to produce a solid biodegradable implant. The present invention is also directed to a method of treating cancer in a patient. The method includes administering to the patient in need of such treatment an effective amount of a flowable composition of the present invention. The present invention is also directed to a method of reducing LHRH levels in a patient. The method includes administering to the patient in need of such LHRH reduction an effective amount of a flowable composition of the present invention. The present invention is also directed to a kit. The kit includes a first container and a second container. The first container includes a composition that includes a biodegradable thermoplastic polyester and a biocompatible polar aprotic solvent. The second container includes leuprolide acetate. The present invention is also directed to a solid implant. The solid implant includes a biocompatible thermoplastic polyester and leuprolide acetate. The solid implant has a solid or gelatinous microporous matrix, wherein the matrix is a core surrounded by a skin. The solid implant can further include a biocompatible organic solvent.
Patent SI-1324764-T1 (SI)
Title: Method for inducing onset of the reproductive cycle of female breeding animals
Inventor: ZAREMBA WOLFGANG
IPC: A61K38/08
Filed: 2001-10-05
Abstract: A method for inducing the onset of the reproductive cycle of female breeding animals is provided. To this end, the animals are injected with an agent that contains synthetically produced FSH releasing hormones as the active substance which comprise known sequences, consisting of 10 amino acids (decapeptide). The active substances are administered to the animals in the form of solution 0 to 96 hours after termination of the preceding anestrus or inhibition or a biotechnical treatment. The agents used promote an onset of the reproductive cycle after the young animals have been weaned from the mature animals and a synchronization of heat in animals that are to be inseminated for the first time.
Patent SI-1368325-T1 (SI)
Title: New asymmetric process for the preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates
Inventor: BROWN WILLIAM
IPC: A61K31/00
Filed: 2002-03-05
Abstract: An asymmetric synthesis of diarylmethylpiperazines is described. The synthetic route enables preparation of a variety of enatiomerically pure amines with different N-alkyl groups. The invention includes an asymmetric addition of organometallic compounds to chiral sulfinimine to give adducts in predominantly one diastereomer can subsequently be transferred into pure enantiomers of by cleavage of the chiral auxilliary which is followed by synthesis of the piperazine ring by alkylation procedures.
Patent SI-1800462-T1 (SI)
Title: Method and apparatus for processing routing requests
Inventor: HINES PATRICK
IPC: H04M3/00
Filed: 2004-11-23
Abstract: The invention provides a method and apparatus for communication and provision of routing address information. The prior owner of a called telephone number is referred to herein as a "prior subscriber". When a number is released by a prior subscriber, it is placed into a database referred to as the " spare spool" which includes available (unsubscribed) telephone numbers. When a caller dials a number that is in the spare pool, the invention intercepts the call (501) and takes any number of possible actions. In one embodiment, the invention automatically forwards the caller to a new number based on a database (502) that stores the new number of the prior subscriber (503) or routes the caller to a message (510) that gives the caller the option (either via a charge or after listening to an advertisement) of being connected to, or being given, the current number of the prior subscriber.
Patent SI-1802540-T1 (SI)
Title: Process for good packaging, namely food stuffs, packagings and kits for their realization
Inventor: STELLIFERI CARLO
IPC: B65B31/00
Filed: 2005-01-20
Abstract: A process for carrying out a packaging for food stuffs, such as hazelnuts, dried fruits, or powdered milk, packaged in bulk, comprises the steps of: —provision of a big bag container (2), —carrying out a filling of the above said product (P), into the big bag container (2.), —provision of a seal enclosure (3) susceptible of containing the big bag container (2) with the above said filling of product (P) therein, and- sealing the enclosure (3) containing the big bag container (2), with the above said filling of product (P) therein, a sub atmospheric pressure. level. Preferably, a protective inert gas, such as nitrogen, is inserted into the enclosure (3) containing the big bag container (2).
Patent SI-1858605-T1 (SI)
Title: Information secure
Inventor: KABITOGLOU GEORGIOS
IPC: A63F3/00
Filed: 2006-02-06
Abstract: According to the invention, in order to secure an information item (4) hidden on an object (2) by a scratch field (3), intermediate layers between the information item (4) and the object (2) are provided with transversal recesses (10, 11) which form the spatial structure thereof. Said recesses (10, 11) are arrangeable on at least one layer (9) in the information item (4) area and/or on at least two layers in an area which surrounds said information item (4) and to which the information item (4) is not applied. In the first case, the parts of the information item (4) are printed on several layers (8, 9) and are disclosable by removing a layer. In the second case, a scalpel is guided to the lower layers devoid of information (4) if they are improperly lifted. <I/>
Patent SI-2307359-T1 (SI)
Title: Blends containing epoxy resins and mixtures of amines with guanidine derivatives
Inventor: DAUN GREGOR
IPC: C07C279/00
Filed: 2009-07-17
Abstract: The present invention provides a blend comprising one or more epoxy resins and a mixture which comprises 0.3 to 0.9 amine equivalent, per equivalent of epoxide of the epoxy resin used, of a hardener component a) and as hardener component b) a compound of the formula I, a process for preparing this blend, the use of the blend of the invention for producing cured epoxy resin, and an epoxy resin cured with the blend of the invention.
Patent DE-3685528-T2 (DE)
Inventor: SHROOT BRAHAM VILLA
IPC: C07D307/68
Filed: 1986-07-25
Granted: 1992-12-24
Abstract: The compounds in question correspond to the following general formula: <IMAGE>  in which: X represents -CH=CH-, O or S, R1 and R2, which may be identical or different, represent a hydrogen atom, a linear or branched alkyl radical having from 1 to 15 carbon atoms or an alkoxy radical having from 1 to 6 carbon atoms, or R1 and R2, taken together and with the adjacent carbon atoms of the naphthalene ring-system, form a 5- or 6-membered ring optionally substituted with at least one lower alkyl radical or interrupted by an oxygen atom, and R3 represents a -CH2OH radical or a radical -COR4, or alternatively a -CH3 radical in the case where R1 and R2, taken together form a 5- or 6-membered ring,  R4 representing -OR5 or <IMAGE> R5 representing a hydrogen atom, an alkyl radical having 1 to 20 carbon atoms, monohydroxyalkyl, polyhydroxyalkyl, aryl or aralkyl radical, optionally substituted, or a sugar residue, or alternatively represents a radical: <IMAGE> p being 1, 2 or 3, r' and r'' representing a hydrogen atom, a lower alkyl radical, a monohydroxyalkyl or polyhydroxyalkyl radical, an optionally substituted aryl radical or an amino acid residue or amino sugar residue, or alternatively, taken together, form a heterocycle, including the salts of the derivatives of formula (I).
Patent DE-3688453-T2 (DE)
Inventor: MARTINEZ ROBERT
IPC: B65D75/36
Filed: 1986-11-17
Granted: 1993-10-28
Abstract: A molded blister package for storing and dispensing a hydrophilic contact lens comprises a base portion which includes a cavity surrounded by a outstanding flange, and a cover sheet sealed to the flange to enclose the cavity. A portion of the side wall of the cavity is inclined to form a ramp to the flange. The cover sheet may be stripped from the flange to expose the cavity and inclined side wall whereupon the lens is readily removed by sliding up and out of the cavity along the inclined surface.
Patent DE-3689017-T2 (DE)
Inventor: COUCHMAN JOHN ROBERT DIAB RES
IPC: C07H3/06
Filed: 1986-07-30
Granted: 1994-01-27
Abstract: Novel esterified oligosaccharides including at least one esterified disaccharide unit consisting of a uronic acid residue and a hexosamine residue can be topically applied to mammalian skin to improve the appearance of hair and other benefits. These oligosaccharides can be synthesised by chemical cleavage of an intact glycosaminoglycan chain or by condensation of hexosamine and uronic acid residues.
Patent DE-3752288-T2 (DE)
Inventor: FORSE NICHOLAS JOHN ARNOLD
IPC: H04W88/02
Filed: 1987-05-29
Granted: 2000-07-06
Abstract: In a speech processor such as a speech recogniser, the problem of detecting the beginning and end of speech or a word accurately, to enable the creation of a speech or a word template which consistently matches stored speech or word templates is solved by characterising background noise and forming a background noise template, setting a speech threshold above which speech is detected and stored, and subtracting the background noise template from the stored speech to form a speech template. <IMAGE>
Patent DE-3787060-T2 (DE)
Inventor: RAGHUNATHAN YEGNASWAMI
IPC: A61K9/18
Filed: 1987-04-14
Granted: 1993-12-02
Abstract: Sulfonic acid cationic exchange resin particles which have been treated to improve their coatability with up to about 20% by weight of a compound selected from hydroxypropylmethyl cellulose, hydroxypropyl cellulose, hydroxypropyl sorbitol, sorbitol, and polyvinylpyrrolidone.
Patent TR-199800822-T2 (TR)
Inventor: ABEL ALBERT E
IPC: A62D3/38
Filed: 1996-10-10
Abstract: Kimyasal savas maddelerinin, tercihe göre, sodyum gibi bir aktif metalin, susuz sivi amonyak gibi bir nitrojenli baz içinde çözülmesi/eritilmesiyle kolayca üretilen solvatlanmis elektronlar içeren nitrojenli bazla tepkimeye sokulmasiyla imha edilebilir. Prosesin gerçeklestirilmesi için kullanilan reaktör sistemi(10) içine nitrojenli bazin veya solvatörden(30) gelen solvatlanmis elektronlarin bir solüsyonunun ve depolama kabindan(40) kimyasal savas maddesinin koyulacagi sekilde düzenlenmis olan tepkime kabini(20) içerir. Reaktör sistemi ayrica tepkime kabindan(20) çikan gazin islenmesi için bir kondansatör(50), tepkime kabindan ürünleri alip, sivi ve kati olarak ayirmak için bir süzme sifonu(60) ve kati bölümün suyla islenip akiskan bir karisim yapildigi bir eritici(80) ve akiskan karisimin oksitlenmesi için bir oksitleyici(80) de içerir.
Patent TR-199802681-T2 (TR)
Inventor: ISRAELSSON ANETTE
IPC: C08J7/056
Filed: 1997-06-19
Abstract: Vücut içindeki bir geçide sokulmak için üzeri bir hidrofilik yüzey ile kaplanmis olan uzun bir safti temsil eden tibbi bir aletin yapilmasi için olan yöntem, bir polieter blok amidi ve bir stiren blok kopolimerden olusan grup içinden seçilmis termoplastik bir elastomer maddeden yapilmis uzatilmis saftin elde edilmesini, (hacime göre agirligin ) %0.05-40'i bir izosanat bilesik içeren bir çözelti ile (hacime göre agirligin) %0.5 ile % 50'si arasinda polivinilprolidon içeren bir çözeltinin söz konusu uzun saftin üzerine sirayla uygulanmasini ve yüksek bir sicaklikta kurutulmasini kapsar.